XML 37 R25.htm IDEA: XBRL DOCUMENT v3.8.0.1
Segment Information
9 Months Ended
Sep. 30, 2017
Segment Information [Abstract]  
Segment Information [Text Block]

Note 17 Segment Information

See Note 1 for a description of the Company’s reporting segments.

In the Company’s segment disclosures, we present “operating revenues,” defined as total revenues excluding realized investment results. The Company excludes realized investment results from this measure because its portfolio managers may sell investments based on factors largely unrelated to the underlying business purposes of each segment. As a result, gains or losses created in this process may not be indicative of the past or future underlying performance of the business.

The Company uses adjusted income (loss) from operations as its principal financial measure of segment operating performance because management believes it best reflects the underlying results of business operations and permits analysis of trends in underlying revenue, expenses and profitability. Adjusted income from operations is defined as shareholders’ net income (loss) excluding after-tax realized investment gains and losses, net amortization of other acquired intangible assets and special items. Income or expense amounts are excluded from adjusted income from operations for the following reasons:

  • Realized investment results are excluded because, as noted above, the Company’s portfolio managers may sell investments based on factors largely unrelated to the underlying business purposes of each segment.
  • Net amortization of other intangible assets is excluded because it relates to costs incurred for acquisitions and, as a result, it does not relate to the core performance of the Company’s business operations.
  • Special items, if any, are excluded because management believes they are not representative of the underlying results of operations. This is generally because the nature and size of these matters are not indicative of our ongoing business operations. Further context about these items is provided in the footnotes listed in the table below.

Three Months Ended
September 30, 2017September 30, 2016
(In millions)Before-taxAfter-taxBefore-taxAfter-tax
Debt extinguishment costs - see Note 5$321 $ 209 $ -$-
Merger-related transaction costs - see Note 3964946
Charges associated with litigation matters - see Note 16(E)--4025
Total impact from special items$330$215$89$71
Nine Months Ended
September 30, 2017September 30, 2016
Before-taxAfter-taxBefore-taxAfter-tax
Debt extinguishment costs - see Note 5$321$209$-$-
Merger-related transaction costs - see Note 3888123108
Long-term care guaranty fund assessment - see Note 16(D)12983--
Charges associated with litigation matters - see Note 16(E)--4025
Total impact from special items$538$300$163$133

Summarized segment financial information was as follows:

(In millions)Global Health CareGlobal Supplemental BenefitsGroup Disability and LifeOther OperationsCorporateTotal
Three Months Ended September 30, 2017
Premiums, fees and other revenues and mail order pharmacy revenues$7,980$954$1,015$29$(11)$9,967
Net investment income893184868298
Operating revenues$8,069$985$1,099$115$(3)$10,265
Total revenues$8,144$985$1,136$120$(3)$10,382
Shareholders' net income (loss)$610$105$97$18$(270)$560
After-tax adjustments to reconcile to adjusted income from operations:
Net realized investment (gains)(47)-(24)(4)-(75)
Amortization of other acquired intangible assets, net124---16
Special items:
Debt extinguishment costs----209209
Merger-related transaction costs----66
Total special items----215215
Adjusted income (loss) from operations$575$109$73$14$(55)$716
(In millions)Global Health CareGlobal Supplemental BenefitsGroup Disability and LifeOther OperationsCorporateTotal
Three Months Ended September 30, 2016
Premiums, fees and other revenues and mail order pharmacy revenues$7,636$837$1,026$28$(4)$9,523
Net investment income772985874282
Operating revenues$7,713$866$1,111$115$-$9,805
Total revenues$7,775$868$1,128$109$-$9,880
Shareholders' net income (loss)$413$77$65$9$(108)$456
After-tax adjustments to reconcile to adjusted income from operations:
Net realized investment (gains) losses(42)-(12)51(48)
Amortization of other acquired intangible assets, net204---24
Special items:
Merger-related transaction costs----4646
Charges associated with litigation matters25----25
Total special items25---4671
Adjusted income (loss) from operations$416$81$53$14$(61)$503

Nine Months Ended September 30, 2017
Premiums, fees and other revenues and mail order pharmacy revenues$24,079$2,759$3,070$89$(35)$29,962
Net investment income2739026226024909
Operating revenues$24,352$2,849$3,332$349$(11)$30,871
Total revenues$24,485$2,861$3,399$351$(11)$31,085
Shareholders' net income (loss)$1,753$283$253$55$(373)$1,971
After-tax adjustments to reconcile to adjusted income from operations:
Net realized investment (gains)(85)(9)(44)(2)-(140)
Amortization of other acquired intangible assets, net4014---54
Special items:
Debt extinguishment costs----209209
Merger-related transaction costs----88
Long-term care guaranty fund assessment68-15--83
Total special items68-15-217300
Adjusted income (loss) from operations$1,776$288$224$53$(156)$2,185
(In millions)Global Health CareGlobal Supplemental BenefitsGroup Disability and LifeOther OperationsCorporateTotal
Nine Months Ended September 30, 2016
Premiums, fees and other revenues and mail order pharmacy revenues$23,207$2,425$3,065$83$(14)$28,766
Net investment income2308225327013848
Operating revenues$23,437$2,507$3,318$353$(1)$29,614
Total revenues$23,510$2,507$3,356$352$(1)$29,724
Shareholders' net income (loss)$1,414$214$81$53$(277)$1,485
After-tax adjustments to reconcile to adjusted income from operations:
Net realized investment (gains) losses(49)1(25)11(71)
Amortization of other acquired intangible assets, net5616---72
Special items:
Merger-related transaction costs----108108
Charges associated with litigation matters25----25
Total special items25---108133
Adjusted income (loss) from operations$1,446$231$56$54$(168)$1,619

The Company had net receivables from CMS of $0.4 billion as of September 30, 2017 and $0.6 billion as of December 31, 2016. These amounts were included in the Consolidated Balance Sheets in premiums, accounts and notes receivable and reinsurance recoverables. Premiums from CMS were 17% of consolidated revenues for the nine months ended September 30, 2017 and 20% for the nine months ended September 30, 2016. These amounts were reported in the Global Health Care segment.